Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Do not freeze and do not shake
But as a standalone agent, Retatrutide outperforms Cagrilintide by a factor of nearly 2.5x
Clean the injection site Begin by washing your hands with soap and water
To meet the diagnostic criteria for cEDS, a person must meet: Major criterion 1 AND major criterion 2 OR Major criterion 1 AND three or more minor criteria Major Criteria Skin hyperextensibility and atrophic scarring Generalized joint hypermobility Minor Criteria Easy bruising Soft, doughy skin Skin fragility (or traumatic splitting) Molluscoid pseudotumors Subcutaneous spheroids Hernia (or history thereof) Epicanthal folds Complications of joint hypermobility (e.g., sprains, dislocations/subluxations, pain, flexible flatfoot) Family history of a first-degree relative who meets clinical criteria Genetic testing is used to see if a person has a genetic variant that causes vEDS
Who should be cautious or avoid injections Some people need special attention
Weeks 13 onward: GHK-Cu 2mg subcutaneous injection 3 times weekly
US$ 20.55
US$ 27.30
US$ 28.21
US$ 26.84
US$ 28.22
